David A. Peura

Medicine · Health Sciences

38h-index5.3kcitations187works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(102), Gastroesophageal reflux and treatments(65), Eosinophilic Esophagitis(57), Gastric Cancer Management and Outcomes(24), Inflammatory mediators and NSAID effects(17)

Publications186 total

Mo1230 GASTRIC INTESTINAL METAPLASIA IS ASSOCIATED WITH THE DEVELOPMENT OF GASTRIC CANCER IN A WESTERN POPULATION PRIMARILY CONSISTING OF CAUCASIAN AMERICANS: A 10-YEAR FOLLOW-UP STUDY
Gastroenterology·2024
Egyptian recommendations for management of Helicobacter pylori infection: 2018 report
Arab Journal of Gastroenterology·2019· 32 cited
Analysis of the symptom response to esomeprazole 20 mg over days 1–4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials
BMJ Open Gastroenterology·2019· 1 citedOpen Access
Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials
BMC Gastroenterology·2018· 5 citedOpen Access
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Gut and Liver·2016· 630 citedOpen Access
Entrevista con el Dr. Barry J. Marshall. Premio Nobel de Medicina por el descubrimiento del Helicobacter pylori
SHILAP Revista de lepidopterología·2016Open Access
A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction
Postgraduate Medicine·2016· 7 cited
Su1133 Durability of Effect Following Resolution of Frequent Heartburn With an Over-the-Counter Regimen of Esomeprazole or Placebo for 14 Days
Gastroenterology·2016
Su1134 Clinical Efficacy Following Attainment of Maximal Acid Control During 14-Day Treatment With Esomeprazole 20 mg in Subjects With Frequent Heartburn
Gastroenterology·2016
Time Course of Improvement in the Frequency and Intensity of Heartburn With Esomeprazole 20 Mg over 14 Days of Treatment
The American Journal of Gastroenterology·2015
Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
Therapeutics and Clinical Risk Management·2015· 7 citedOpen Access
Efficacy of 14-Day Treatment With Esomeprazole 20 mg According to Baseline Heartburn Frequency: A Pooled Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
The American Journal of Gastroenterology·2014
Durability of Effect and Lack of Rebound Symptoms Following a 14-Day Regimen of Esomeprazole 20 mg Treatment in Patients With Frequent Heartburn
The American Journal of Gastroenterology·2014
Esomeprazole Treatment of Frequent Heartburn: Two Randomized, Double-Blind, Placebo-Controlled Trials
Postgraduate Medicine·2014· 10 cited
Tu1117 Resolution and Early Relief of Frequent Heartburn With a 14-Day Regimen of Esomeprazole 20 mg: Results From 2 Multicenter, Randomized, Double-Blind Trials in Subjects With Frequent Heartburn Who Are Likely to Self-Treat With Over-the-Counter Medications
Gastroenterology·2014· 1 cited
Tu1116 A 14-Day Regimen of Esomeprazole 20 mg Was Effective in Increasing Heartburn-Free 24-Hour Days: Results From 2 Randomized, Double-Blind Trials in Subjects With Frequent Heartburn Who Are Likely to Self-Treat With Over-the-Counter Medications
Gastroenterology·2014· 1 citedOpen Access
Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of concept analysis
Journal of Drug Assessment·2014· 4 citedOpen Access
P1. A Single Paraffin-Embedded or RNA-Later-Preserved Esophageal Biopsy Is Valid for Genetic Diagnosis of Eosinophilic Esophagitis Regardless of Location in the Esophagus
2014
Aspirin and Proton Pump Inhibitor Combination Therapy for Prevention of Cardiovascular Disease and Barrett's Esophagus
Postgraduate Medicine·2014· 8 cited
Belladonna Alkaloid/Phenobarbital (Donnatal™) Effective for Treating IBS Symptoms
2014· 1 cited
page 1 of 10Next →

Frequent Co-authors

Lawrence F. Johnson(4), Betsy Pilmer(3), Andrew Y. Wang(3), Francis K.L. Chan(3), Jay L. Goldstein(3), James M. Scheiman(3), Barry J. Marshall(3), Frank L. Lanza(2), P G Foutch(2), Sheila E. Crowe(2), Stuart Atkinson(2), David C. Metz(2), Nancy Siepman(2), Sarah R. Hoffman(2), James T. Patrie(2), Zachary Henry(2), Richard W. McCallum(2), Roy K.H. Wong(2), Ángel Lanas(2), C. Mel Wilcox(2)